Pyramid Announces Appointment of Amy Driver as Business Development Leader
12 Sep 2023 //
BUSINESSWIRE
Pyramid deviates from TRK with deal for rival to Gilead ADC
14 Apr 2023 //
FIERCE BIOTECH
Pyramid Bio to Present at the 2022 Jefferies London Healthcare Conference
03 Nov 2022 //
BUSINESSWIRE
Pyramid Biosciences Names Biren Amin as Chief Financial and Strategy Officer
07 Sep 2022 //
BUSINESSWIRE
Pyramid Biosciences Receives Orphan Drug Designation for PBI-200 From FDA
06 Jul 2022 //
BUSINESSWIRE
Pyramid Bio, Caris Collaborate for Trial in NTRK Fusion Solid Tumors
10 Mar 2022 //
PRNEWSWIRE
Pyramid Biosciences Announces Initial Closing of Series B Financing
27 Oct 2021 //
BUSINESSWIRE
Pyramid Biosciences Announces 1st Patients Dosed in Phase 1 Clinical Program
20 May 2021 //
BUSINESSWIRE